Already current practice? A snapshot survey on doxycycline use for prevention of sexually transmitted infections in parts of the German MSM community
Authors:
Open Access
- 22 August 2023
- journal article
- research article
- Published by Springer Nature in Infection
- Vol. 51 (6) , 1831-1834
Abstract
Purpose: Recent studies point toward a potential benefit of doxycycline use for post-exposure prophylaxis (PEP) or pre-exposure prophylaxis (PrEP) to prevent sexually transmitted infections (STIs). Although prescribing doxycycline in a prophylactic intention is not generally recommended yet, we noticed an increasing number of inquiries from individuals within the LGBTQ community for doxycycline prescriptions. Methods: We conducted an anonymous online survey to evaluate the current extent of doxycycline use for PEP or PrEP within the LGBTQ community using REDCap electronic data capture tools. Participants gained access to the online survey through a QR code on posters in the premises of our STI outpatient department and at LGBTQ community-related events in the south-western region of Germany. Additional access was provided by a direct link shared on social media profiles for men having sex with men (MSM), transgender, and queers. Results: 96 of 99 responses were eligible for analysis. Twenty-two participants (23%) indicated to have already used doxycycline for PEP and six participants (6%) used doxycycline for PrEP. The majority of participants used pills left over from previous doxycycline treatment. Forty percent of indicated modes of access were without a regular prescription, e.g., by provision from acquaintances (with or without healthcare profession) or by ordering online. Conclusion: Our study shows that the concept of doxycycline use for prevention of STIs is already well known and applied in the LGBTQ community. Further analysis, especially modeling studies, are needed to evaluate strategies aiming to reduce doxycycline intake (PEP/PrEP versus repeated targeted therapies) and improve sexual health outcomes within the community.Keywords
Funding Information
- Universitätsklinikum Freiburg
This publication has 10 references indexed in Scilit:
- Selection of Neisseria gonorrhoeae ceftriaxone resistance using doxycycline post-exposure prophylaxisThe Lancet Infectious Diseases, 2023
- Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted InfectionsNew England Journal of Medicine, 2023
- Interim position statement on doxycycline post-exposure prophylaxis (Doxy-PEP) for the prevention of bacterial sexually transmissible infections in Australia and Aotearoa New Zealand – the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM)Sexual Health, 2023
- Awareness and willingness to accept syphilis chemoprophylaxis among men who have sex with men from three cities in China: a cross-sectional studyBMC Public Health, 2022
- Doxycycline as an antimalarial: Impact on travellers’ diarrhoea and doxycycline resistance among various stool bacteria – Prospective study and literature reviewTravel Medicine and Infectious Disease, 2022
- Emergence of antibiotic-resistant Mycoplasma genitalium as the cause of non-gonococcal urethritis in male patients at a sexually transmitted infection clinicInternational Journal of Antimicrobial Agents, 2022
- Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2020
- The REDCap consortium: Building an international community of software platform partnersJournal of Biomedical Informatics, 2019
- Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trialThe Lancet Infectious Diseases, 2018
- Doxycycline Prophylaxis to Reduce Incident Syphilis among HIV-Infected Men Who Have Sex With Men Who Continue to Engage in High-Risk SexSexually Transmitted Diseases, 2015